The phenotype of variant carriers (Tables 1 and 2) and the segregation pattern (Supplemental Figure 5, Family 14) suggest that the variant leads to HNF4A-MODY with reduced penetrance in addition to a delayed onset of disease and not being a risk factor for type 2 diabetes development. Here, HNF4A is linked to MODY.